section name header

Table 1-4

Causes of Hyperkalemia

I. “Pseudo” hyperkalemia

  1. Cellular efflux: thrombocytosis, erythrocytosis, leukocytosis, in vitro hemolysis
  2. Hereditary defects in red cell membrane transport

II. Intra- to extracellular shift

  1. Acidosis
  2. Hyperosmolality; radiocontrast, hypertonic dextrose, mannitol
  3. β-Adrenergic antagonists (noncardioselective agents)
  4. Digoxin and related glycosides (yellow oleander, foxglove, bufadienolide)
  5. Hyperkalemic periodic paralysis
  6. Lysine, arginine, and -aminocaproic acid (structurally similar, positively charged)
  7. Succinylcholine; thermal trauma, neuromuscular injury, disuse atrophy, mucositis, or prolonged immobilization
  8. Rapid tumor lysis

III. Inadequate excretion

  1. Inhibition of the renin-angiotensin-aldosterone axis; risk of hyperkalemia when used in combination or at higher than recommended dosages
    1. ACE inhibitors
    2. Renin inhibitors: aliskiren (in combination with ACE inhibitors or ARBs)
    3. ARBs
    4. Blockade of the mineralocorticoid receptor: spironolactone, eplerenone, drospirenone
    5. Blockade of ENaC: amiloride, triamterene, trimethoprim, pentamidine, nafamostat
  2. Decreased distal delivery
    1. Congestive heart failure
    2. Volume depletion
  3. Hyporeninemic hypoaldosteronism
    1. Tubulointerstitial diseases: SLE, sickle cell anemia, obstructive uropathy
    2. Diabetes, diabetic nephropathy
    3. Drugs: nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, β blockers, cyclosporine, tacrolimus
    4. Chronic kidney disease, advanced age
    5. Pseudohypoaldosteronism type II: defects in WNK1 or WNK4 kinases, Kelch-like 3 (KLHL3), or Cullin 3 (CUL3)
  4. Renal resistance to mineralocorticoid
    1. Tubulointerstitial diseases: SLE, amyloidosis, sickle cell anemia, obstructive uropathy, post-acute tubular necrosis
    2. Hereditary: pseudohypoaldosteronism type I: defects in the mineralocorticoid receptor or ENaC
  5. Advanced renal insufficiency with low GFR
    1. Chronic kidney disease
    2. End-stage renal disease
    3. Acute oliguric kidney injury
  6. Primary adrenal insufficiency
    1. Autoimmune: Addison's disease, polyglandular endocrinopathy
    2. Infectious: HIV, cytomegalovirus, tuberculosis, disseminated fungal infection
    3. Infiltrative: amyloidosis, malignancy, metastatic cancer
    4. Drug-associated: heparin, low-molecular-weight heparin
    5. Hereditary: adrenal hypoplasia congenita, congenital lipoid adrenal hyperplasia, aldosterone synthase deficiency
    6. Adrenal hemorrhage or infarction, including in antiphospholipid syndrome

Abbreviations: ARB, angiotensin receptor blocker; COX-2, cyclooxygenase 2; ENaC, epithelial Na+ channels.